MedTrace Logo

Effects of Periodontal Therapy on Systemic Inflammation

NCT01046435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2010-03-25

No results posted yet for this study

Summary

The purpose of this study is to determine if treating periodontal infections (gum disease) will reduce markers of systemic inflammation in patients at risk of cardiovascular diseases.

Conditions

Interventions

PROCEDURE

metronidazole and amoxicillin

Metronidazole 250 mg three times a day per 7 days

PROCEDURE

Two placebos

Two placebos 3 times a day for 7 days

Sponsors & Collaborators

  • University of Chile

    lead OTHER

Principal Investigators

  • Nestor J. Lopez, DDS · University of Chile

  • Antonio Quintero, DDS · University of Chile

  • Carola Ibieta, DDS · University of Chile

  • Carlos Y Valenzuela, DMS, PhD · University of Chile

  • Lilian Jara, MsB, PhD · University of Chile

  • Marcelo Llancaqueo, DMS · University of Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01046435 on ClinicalTrials.gov